[P.E. Biopharm Corporation] 2026 Q1 EPS -1.18 NTD
NQ Score
0/100
N1 Content Completeness
3
AI Summary (NQ-processed)
P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The company's operating revenue was 0.06 billion NTD, and net profit after tax was -0.87 billion NTD, indicating a loss-making quarter.